エピソード

  • Innovations in Healthcare: Stryker's FDA Approval, OneMedNet's Funding, and CHMP's Nod to RYBREVANT
    2024/08/01
    Recent Advances in Medical Technologies and Therapies: Stryker's innovative spine surgery technology receives FDA approval, OneMedNet raises $4.6 million in private funding, and the CHMP endorses RYBREVANT® (amivantamab) combined with chemotherapy for advanced EGFR-mutated NSCLC post-therapy failure.
    続きを読む 一部表示
    5 分
  • Innovative Horizons: Johnson And Johnson's Medical Advances and EMVision's Portable Brain Scanner Revolution
    2024/07/25
    Recent Developments in Medical Technology: Johnson and Johnson Dedicate Efforts to Medical Innovation, While Australian Medtech EMVision Introduces a Portable Brain Scanner for First Responders, and Advances in Personalized Computer System-Based Therapy Improve Post-Stroke Rehabilitation.
    続きを読む 一部表示
    5 分
  • MedTech Momentum: Johnson & Johnson's Q2 Outlook, Bedal's $11m Leap, and CMR Surgical's New Chairman
    2024/07/19
    Recent headlines in the medical technology sector include Johnson & Johnson potentially leveraging MedTech to boost its Q2 performance, Bedal raising $11 million to enhance the growth of its FlexGRIP catheter device, and CMR Surgical appointing Daniel Moore as the new Non-Executive Chairman.
    続きを読む 一部表示
    5 分
  • MedTech Innovations Surge: Johnson & Johnson's Q2, Bedal's $11m Boost, and CMR Surgical's Leadership Change
    2024/07/18
    MedTech Highlights: Johnson & Johnson potentially boosts Q2 with MedTech, Bedal raises $11 million to expand FlexGRIP catheter device, and CMR Surgical names Daniel Moore as Non-Executive Chairman.
    続きを読む 一部表示
    6 分
  • Medikabazaar Leadership Shake-Up and Breakthrough Trends in MedTech 2024
    2024/07/11
    Medtech Industry Updates: Medikabazaar Rejigs Leadership, 2024 Trends Identified

    Medikabazaar has reshuffled its top management following findings from a PwC audit, while recent reports by Clarivate and a 2024 cybersecurity survey highlight emerging breakthrough trends and security concerns in the medtech sector.
    続きを読む 一部表示
    6 分
  • Breakthroughs and Leadership in MedTech: Insights on Clarivate, Jin Medical, Sanara, and Advanced MedTech Trends
    2024/07/04
    In 2024, Clarivate highlights six significant MedTech trends poised to create new industry opportunities. Additionally, an analysis compares Jin Medical International and Sanara MedTech's performance, while Advanced MedTech reports record revenues for the fiscal year alongside announcing a leadership change.
    続きを読む 一部表示
    8 分
  • AI MedTech Innovations: Insights from Sanara MedTech and IQVIA's Latest Achievements
    2024/06/27
    Recent developments in the healthcare and technology sectors show promising progress. Sanara MedTech's stock has seen a rise of 3.6% on NASDAQ. Meanwhile, PEAK:AIO is dedicating efforts towards advancing AI in healthcare. Additionally, IQVIA's SmartSolve® eQMS has been recognized with the 2024 MedTech Breakthrough Award for the Best Use of Artificial Intelligence in Healthcare, highlighting innovations in the industry.
    続きを読む 一部表示
    6 分
  • Navigating Innovations and Acquisitions: Salesforce, Boston Scientific, and PROCEPT BioRobotics at the Truist Securities MedTech Conference
    2024/06/20
    Recent updates in the medical technology sector include PROCEPT BioRobotics participating in the Truist Securities MedTech Conference, Boston Scientific's agreement to acquire Silk Road Medical for approximately $1.26 billion, and Salesforce.com launching an AI-powered Life Sciences Cloud to enhance engagements between pharma, MedTech companies, patients, and healthcare professionals.
    続きを読む 一部表示
    6 分